1,188 filings
Page 3 of 60
8-K
80nepsdx55elfs
2 Jun 20
Entry into a Material Definitive Agreement
7:35am
8-K
9pij4o
8 May 20
VIVUS Q1 2020 Earnings Conference Call
4:45pm
8-K
1j2voc
6 May 20
VIVUS Reports First Quarter 2020 Financial Results
4:10pm
8-K
gwnzm bnjwlvnwv2xz
1 May 20
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt
8:30am
CT ORDER
7e3zvk 42fratk0dwc
24 Apr 20
Confidential treatment order
2:36pm
SC 13G
zl8zeqx2s2mfco0
13 Apr 20
VIVUS / ARMISTICE CAPITAL ownership change
4:35pm
SC 13G
4igyoia83l
10 Apr 20
VIVUS / INTRACOASTAL CAPITAL ownership change
4:27pm
8-K
4wdmw
3 Apr 20
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
3:05pm
8-K
0w71vh 58faqt
2 Apr 20
Entry into a Material Definitive Agreement
5:28pm
424B5
fs0709m9o4jh dgw
2 Apr 20
Prospectus supplement for primary offering
2:01pm
8-K
f40u qku8
1 Apr 20
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:00pm
SC 13G
gb17m5vyh1
1 Apr 20
VIVUS / SABBY MANAGEMENT ownership change
9:24am
8-K
kak7yao7rb 60v
31 Mar 20
Other Events
7:35am
CT ORDER
5c6 ai5uz9f3pn
12 Mar 20
Confidential treatment order
1:06pm
8-K
7e3kagh90
6 Mar 20
VIVUS Q4 2019 Earnings Conference Call
4:05pm
424B5
gvk6vy
6 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
8dalxzvm5g9g1s
6 Mar 20
Entry into a Material Definitive Agreement
12:00am
8-K
qkw41 vuhv2m
3 Mar 20
VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm